Lopresti, Adrian L.

A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers

Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Tryptophan and brain disordersTreatment of Major Depression

Cited by 371

An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study

Lopresti, A. L., Smith, S. J., Malvi, H., & Kodgule, R. (2019) · Medicine

Phytochemicals and Medicinal PlantsMedicinal Plant Extracts Effects

Cited by 241

Obesity and psychiatric disorders: Commonalities in dysregulated biological pathways and their implications for treatment

Lopresti, A. L., & Drummond, P. D. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Eating Disorders and BehaviorsRegulation of Appetite and Obesity

Cited by 231

Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study

Lopresti, A. L., Maes, M., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Journal of Affective Disorders

Curcumin's Biomedical ApplicationsTreatment of Major Depression

Cited by 216

Curcumin and major depression: A randomised, double-blind, placebo-controlled trial investigating the potential of peripheral biomarkers to predict treatment response and antidepressant mechanisms of change

Lopresti, A. L., Maes, M., Meddens, M. J. M., Maker, G. L., Arnoldussen, E., & Drummond, P. D. (2015) · European Neuropsychopharmacology

Curcumin's Biomedical ApplicationsTreatment of Major Depression

Cited by 99